Clinical Trials Directory

Trials / Sponsors / BeBetter Med Inc

BeBetter Med Inc

Industry · 13 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Choles
Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol
Phase 1 / Phase 22026-01-26
Not Yet RecruitingStudy of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)
Polycythemia Vera
Phase 12025-06-05
RecruitingStudy Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 32025-01-06
Not Yet RecruitingStudy of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations
Non Small Cell Lung Cancer
Phase 22024-07-01
UnknownStudy of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 12023-12-01
UnknownStudy of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation
Advanced or Metastatic Solid Tumor, KRAS G12C Mutation
Phase 12023-09-04
RecruitingA Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Canc
Advanced Triple-Negative Breast Cancer
Phase 22023-04-12
CompletedStudy of Orally Administered BEBT-503 in Healthy Subjects
Healthy Subjects
Phase 12022-08-26
RecruitingStudy of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients W
HR+/HER2- Locally Advanced, Metastatic Breast Cancer
Phase 32022-06-09
RecruitingStudy of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
Phase 22022-04-15
UnknownStudy of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects
Relapsed or Refractory Diffuse Large B-cell Lymphoma
Phase 22020-06-12
UnknownPhase I Study of BEBT-209 in Women With Advanced Breast Cancer
Advanced Breast Cancer
Phase 12019-07-15
CompletedStudy of BEBT-908 in Subjects With Advanced Hematological Tumors
Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma
Phase 12016-03-02